 <h1>Prilosec Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>omeprazole</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about omeprazole. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Prilosec.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to omeprazole: oral capsule delayed release, oral packet, oral powder for suspension, oral tablet delayed release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, omeprazole (the active ingredient contained in Prilosec) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking omeprazole:</p><p>
<i>Rare</i>
</p><ul>
<li>Back, leg, or stomach pain</li>
<li>bleeding or crusting sores on the lips</li>
<li>blisters</li>
<li>bloody or cloudy urine</li>
<li>chills</li>
<li>continuing ulcers or sores in the mouth</li>
<li>difficult, burning, or painful urination</li>
<li>fever</li>
<li>frequent urge to urinate</li>
<li>general feeling of discomfort or illness</li>
<li>itching, skin rash</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>muscle aches or cramps</li>
<li>pain</li>
<li>red or irritated eyes</li>
<li>redness, tenderness, itching, burning, or peeling of the skin</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips, in the mouth, or on the genitals</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>drowsiness</li>
<li>fast, racing, or uneven heartbeat</li>
<li>mood or mental changes</li>
<li>muscle spasms (tetany) or twitching seizures</li>
<li>nausea</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>trembling</li>
<li>vomiting</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking omeprazole:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Blurred vision</li>
<li>confusion</li>
<li>dryness of the mouth</li>
<li>flushing</li>
<li>headache</li>
<li>increased sweating</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of omeprazole may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Body aches or pain</li>
<li>chest pain</li>
<li>constipation</li>
<li>cough</li>
<li>diarrhea or loose stools</li>
<li>difficulty with breathing</li>
<li>dizziness</li>
<li>ear congestion</li>
<li>gas</li>
<li>heartburn</li>
<li>loss of voice</li>
<li>muscle pain</li>
<li>nasal congestion</li>
<li>runny nose</li>
<li>sneezing</li>
<li>unusual drowsiness</li>
</ul><p>
<!-- end oral capsule delayed release, oral packet, oral powder for suspension, oral tablet delayed release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to omeprazole: compounding powder, oral delayed release capsule, oral delayed release tablet, oral powder for reconstitution, oral powder for reconstitution delayed release, oral suspension</i></p><h3>General</h3><p>The most commonly reported side effects included headache, abdominal pain, nausea, and diarrhea.<sup>[Ref]</sup></p><h3>Other</h3><p>Otitis media occurred most frequently in patients 1 month to less than 1 year of age.</p>
<p></p>
<p>Fever most commonly occurred in patients 1 to less than 2 years of age.</p>
<p></p>
<p>Accidental injury most commonly occurred in patients 2 to 16 years of age.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Fever (up to 33%), otitis media (up to 22%)</p>
<p><b>Common</b> (1% to 10%): Accidental injury, asthenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Malaise</p>
<p><b>Very rare</b> (less than 0.01%): Elevated body temperature</p>
<p><b>Postmarketing reports</b>: Pain, fatigue, tinnitus<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Patients 1 to less than 2 years of age had the highest frequency of adverse reactions of the respiratory system, followed by patients 1 month to less than 1 year and patients 2 to 16 years of age.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Respiratory system reactions (up to 75%)</p>
<p><b>Common</b> (1% to 10%): Cough, pharyngitis/pharyngeal pain, rhinitis, upper respiratory infection</p>
<p><b>Rare</b> (0.01% to 0.1%): Bronchospasm</p>
<p><b>Very rare</b> (less than 0.01%): Dyspnea</p>
<p><b>Postmarketing reports</b>: Epistaxis<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Lightheadedness occurred predominantly in severely ill or elderly patients.</p>
<p></p>
<p>Taste disturbance usually resolved when treatment was stopped.</p>
<p></p>
<p>Taste perversion most commonly occurred in patients given concomitant treatment with clarithromycin.</p>
<p></p>
<p>Hepatic encephalopathy occurred in patients with preexisting liver disease.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Taste perversion (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, drowsiness, headache, somnolence</p>
<p><b>Uncommon</b> (0.1% to 1%): Paresthesia, taste disturbances, vertigo</p>
<p><b>Rare</b> (0.01% to 0.1%): Hepatic encephalopathy, lightheadedness</p>
<p><b>Postmarketing reports</b>: Tremor<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Hemorrhagic necrotic gastritis has been reported in pediatric patients.</p>
<p></p>
<p>Diarrhea most commonly occurred in patients given concomitant treatment with clarithromycin and amoxicillin.</p>
<p></p>
<p>Benign gastric fundic gland polyps appeared to be reversible when omeprazole (the active ingredient contained in Prilosec) was discontinued.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Diarrhea (Up to 14%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, acid regurgitation, benign fundic gland polyps, constipation, flatulence, nausea, tongue discoloration, vomiting</p>
<p><b>Rare</b> (0.01% to 0.1%): Dry mouth, gastrointestinal candidiasis, microscopic colitis, stomatitis</p>
<p><b>Very rare</b> (less than 0.01%): Dyspepsia, hemorrhagic necrotic gastritis</p>
<p><b>Postmarketing reports</b>: Abdominal swelling, Clostridium difficile associated diarrhea, esophageal candidiasis, fecal discoloration, fundic gland polyps, irritable colon, mucosal atrophy of the tongue, pancreatitis (sometimes fatal)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Alopecia, dermatitis, erythema multiforme, increased sweating, pruritus, photosensitivity, skin eruptions, urticaria</p>
<p><b>Rare</b> (0.01% to 0.1%): Allergic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis (some fatal)</p>
<p><b>Frequency not reported</b>: Subacute cutaneous lupus erythematosus</p>
<p><b>Postmarketing reports</b>: Cutaneous lupus erythematosus, dry skin, hyperhidrosis, petechia, skin inflammation, severe generalized skin reactions, systemic lupus erythematosus<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Fracture of the hip/wrist/spine</p>
<p><b>Rare</b> (0.01% to 0.1%): Arthralgia, joint pain, muscular weakness, myalgia</p>
<p><b>Postmarketing reports</b>: Bone fracture, leg pain, muscle cramps<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Confusion, agitation, aggression, depression, and hallucinations occurred predominantly in severely ill or elderly patients.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Insomnia</p>
<p><b>Rare</b> (0.01% to 0.1%): Aggression, agitation, confusion/reversible mental confusion, depression, hallucinations</p>
<p><b>Postmarketing reports</b>: Anxiety, apathy, dream abnormalities, nervousness, psychiatric and sleep disturbances<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Flu syndrome<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Increased liver enzymes (ALT, alkaline phosphatase, AST, bilirubin, gamma glutamyl transferase)</p>
<p><b>Rare</b> (0.01% to 0.1%): Hepatic failure, hepatitis with/without jaundice</p>
<p><b>Postmarketing reports</b>: Cholestatic disease, fatal hepatic failure, hepatocellular disease, jaundice, liver disease, liver necrosis (some fatal), mixed hepatitis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Peripheral edema</p>
<p><b>Postmarketing reports</b>: Bradycardia, chest pain/angina, elevated blood pressure/hypertension, palpitations, tachycardia<sup>[Ref]</sup></p><p>Peripheral edema usually resolved when treatment was stopped.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (0.01% to 0.1%): Agranulocytosis, hypochromic/microcytic anemia, leukopenia, pancytopenia, thrombocytopenia</p>
<p><b>Postmarketing reports</b>: Anemia, fatal agranulocytosis, hemolytic anemia, leukocytosis, neutropenia, purpura<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Anaphylactic reaction/shock, angioedema, hypersensitivity reactions</p>
<p><b>Postmarketing reports</b>: Anaphylaxis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (0.01% to 0.1%): Hyponatremia</p>
<p><b>Very rare</b> (less than 0.01%): Hypocalcemia, hypokalemia, hypomagnesemia with/without hypocalcemia and/or hypokalemia, weight increase</p>
<p><b>Postmarketing reports</b>: Anorexia, cyanocobalamin (vitamin B12) deficiency, hypoglycemia<sup>[Ref]</sup></p><p>Severe hypomagnesemia may result in hypocalcemia, and this condition may be associated with hypokalemia.</p>
<p></p>
<p>Hypokalemia was reported in pediatric patients.<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (0.01% to 0.1%): Interstitial nephritis</p>
<p><b>Very rare</b> (less than 0.01%): Impaired renal function, nephrosis</p>
<p><b>Postmarketing reports</b>: Elevated serum creatinine, glycosuria<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (0.01% to 0.1%): Blurred vision</p>
<p><b>Frequency not reported</b>: Irreversible visual impairment</p>
<p><b>Postmarketing reports</b>: Anterior ischemic optic neuropathy, double vision, dry eye syndrome, ocular irritation, optic atrophy, optic neuritis<sup>[Ref]</sup></p><p>Irreversible visual impairment has been reported in critically ill patients who generally received high doses of the IV formulation as a bolus; however, no causal relationship has been established.<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Rare</b> (0.01% to 0.1%): Gynecomastia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very rare</b> (less than 0.01%): Impotence</p>
<p><b>Postmarketing reports</b>: Hematuria, microscopic pyuria, proteinuria, testicular pain, urinary frequency, urinary tract infection<sup>[Ref]</sup></p><p>A causal relationship between this drug and impotence has not been established.<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Postmarketing reports</b>: Gastroduodenal carcinoids<sup>[Ref]</sup></p><p>Gastroduodenal carcinoids have been reported in patients with Zollinger-Ellison syndrome on long-term therapy.  This condition may be a manifestation of the underlying condition, which is known to be associated with tumors.<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Zegerid (omeprazole)." Santarus Inc, San Diego, CA. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. "Product Information. Prilosec (omeprazole)." Merck &amp; Co, Inc, West Point, PA. </p><p id="ref_5">5. "Product Information. Omeprazole (omeprazole)." Mylan Pharmaceuticals Inc, Morgantown, WV. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>When is the best time to take omeprazole, before or after a meal?</li>
<li>Nexium vs Prilosec: What's the difference between them?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Prilosec (omeprazole)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>43 Reviews</li>
<li>Drug class: proton pump inhibitors</li>
<li>FDA Alerts (6)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Prilosec &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Prilosec OTC</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Barrett's Esophagus</li>
<li>GERD</li>
<li>Duodenal Ulcer</li>
<li>Erosive Esophagitis</li>
<li data-more-config-id="list-data-resources-conditions">... +6 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to omeprazole: compounding powder, oral delayed release capsule, oral delayed release tablet, oral powder for reconstitution, oral powder for reconstitution delayed release, oral suspension</i></p><h3>General</h3><p>The most commonly reported side effects included headache, abdominal pain, nausea, and diarrhea.<sup>[Ref]</sup></p><h3>Other</h3><p>Otitis media occurred most frequently in patients 1 month to less than 1 year of age.</p><p></p><p>Fever most commonly occurred in patients 1 to less than 2 years of age.</p><p></p><p>Accidental injury most commonly occurred in patients 2 to 16 years of age.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Fever (up to 33%), otitis media (up to 22%)</p><p><b>Common</b> (1% to 10%): Accidental injury, asthenia</p><p><b>Uncommon</b> (0.1% to 1%): Malaise</p><p><b>Very rare</b> (less than 0.01%): Elevated body temperature</p><p><b>Postmarketing reports</b>: Pain, fatigue, tinnitus<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Patients 1 to less than 2 years of age had the highest frequency of adverse reactions of the respiratory system, followed by patients 1 month to less than 1 year and patients 2 to 16 years of age.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Respiratory system reactions (up to 75%)</p><p><b>Common</b> (1% to 10%): Cough, pharyngitis/pharyngeal pain, rhinitis, upper respiratory infection</p><p><b>Rare</b> (0.01% to 0.1%): Bronchospasm</p><p><b>Very rare</b> (less than 0.01%): Dyspnea</p><p><b>Postmarketing reports</b>: Epistaxis<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Lightheadedness occurred predominantly in severely ill or elderly patients.</p><p></p><p>Taste disturbance usually resolved when treatment was stopped.</p><p></p><p>Taste perversion most commonly occurred in patients given concomitant treatment with clarithromycin.</p><p></p><p>Hepatic encephalopathy occurred in patients with preexisting liver disease.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Taste perversion (up to 15%)</p><p><b>Common</b> (1% to 10%): Dizziness, drowsiness, headache, somnolence</p><p><b>Uncommon</b> (0.1% to 1%): Paresthesia, taste disturbances, vertigo</p><p><b>Rare</b> (0.01% to 0.1%): Hepatic encephalopathy, lightheadedness</p><p><b>Postmarketing reports</b>: Tremor<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Hemorrhagic necrotic gastritis has been reported in pediatric patients.</p><p></p><p>Diarrhea most commonly occurred in patients given concomitant treatment with clarithromycin and amoxicillin.</p><p></p><p>Benign gastric fundic gland polyps appeared to be reversible when omeprazole (the active ingredient contained in Prilosec) was discontinued.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Diarrhea (Up to 14%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, acid regurgitation, benign fundic gland polyps, constipation, flatulence, nausea, tongue discoloration, vomiting</p><p><b>Rare</b> (0.01% to 0.1%): Dry mouth, gastrointestinal candidiasis, microscopic colitis, stomatitis</p><p><b>Very rare</b> (less than 0.01%): Dyspepsia, hemorrhagic necrotic gastritis</p><p><b>Postmarketing reports</b>: Abdominal swelling, Clostridium difficile associated diarrhea, esophageal candidiasis, fecal discoloration, fundic gland polyps, irritable colon, mucosal atrophy of the tongue, pancreatitis (sometimes fatal)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Uncommon</b> (0.1% to 1%): Alopecia, dermatitis, erythema multiforme, increased sweating, pruritus, photosensitivity, skin eruptions, urticaria</p><p><b>Rare</b> (0.01% to 0.1%): Allergic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis (some fatal)</p><p><b>Frequency not reported</b>: Subacute cutaneous lupus erythematosus</p><p><b>Postmarketing reports</b>: Cutaneous lupus erythematosus, dry skin, hyperhidrosis, petechia, skin inflammation, severe generalized skin reactions, systemic lupus erythematosus<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain</p><p><b>Uncommon</b> (0.1% to 1%): Fracture of the hip/wrist/spine</p><p><b>Rare</b> (0.01% to 0.1%): Arthralgia, joint pain, muscular weakness, myalgia</p><p><b>Postmarketing reports</b>: Bone fracture, leg pain, muscle cramps<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Confusion, agitation, aggression, depression, and hallucinations occurred predominantly in severely ill or elderly patients.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Insomnia</p><p><b>Rare</b> (0.01% to 0.1%): Aggression, agitation, confusion/reversible mental confusion, depression, hallucinations</p><p><b>Postmarketing reports</b>: Anxiety, apathy, dream abnormalities, nervousness, psychiatric and sleep disturbances<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Flu syndrome<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Increased liver enzymes (ALT, alkaline phosphatase, AST, bilirubin, gamma glutamyl transferase)</p><p><b>Rare</b> (0.01% to 0.1%): Hepatic failure, hepatitis with/without jaundice</p><p><b>Postmarketing reports</b>: Cholestatic disease, fatal hepatic failure, hepatocellular disease, jaundice, liver disease, liver necrosis (some fatal), mixed hepatitis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Peripheral edema</p><p><b>Postmarketing reports</b>: Bradycardia, chest pain/angina, elevated blood pressure/hypertension, palpitations, tachycardia<sup>[Ref]</sup></p><p>Peripheral edema usually resolved when treatment was stopped.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (0.01% to 0.1%): Agranulocytosis, hypochromic/microcytic anemia, leukopenia, pancytopenia, thrombocytopenia</p><p><b>Postmarketing reports</b>: Anemia, fatal agranulocytosis, hemolytic anemia, leukocytosis, neutropenia, purpura<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Anaphylactic reaction/shock, angioedema, hypersensitivity reactions</p><p><b>Postmarketing reports</b>: Anaphylaxis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (0.01% to 0.1%): Hyponatremia</p><p><b>Very rare</b> (less than 0.01%): Hypocalcemia, hypokalemia, hypomagnesemia with/without hypocalcemia and/or hypokalemia, weight increase</p><p><b>Postmarketing reports</b>: Anorexia, cyanocobalamin (vitamin B12) deficiency, hypoglycemia<sup>[Ref]</sup></p><p>Severe hypomagnesemia may result in hypocalcemia, and this condition may be associated with hypokalemia.</p><p></p><p>Hypokalemia was reported in pediatric patients.<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Rare</b> (0.01% to 0.1%): Interstitial nephritis</p><p><b>Very rare</b> (less than 0.01%): Impaired renal function, nephrosis</p><p><b>Postmarketing reports</b>: Elevated serum creatinine, glycosuria<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (0.01% to 0.1%): Blurred vision</p><p><b>Frequency not reported</b>: Irreversible visual impairment</p><p><b>Postmarketing reports</b>: Anterior ischemic optic neuropathy, double vision, dry eye syndrome, ocular irritation, optic atrophy, optic neuritis<sup>[Ref]</sup></p><p>Irreversible visual impairment has been reported in critically ill patients who generally received high doses of the IV formulation as a bolus; however, no causal relationship has been established.<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Rare</b> (0.01% to 0.1%): Gynecomastia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very rare</b> (less than 0.01%): Impotence</p><p><b>Postmarketing reports</b>: Hematuria, microscopic pyuria, proteinuria, testicular pain, urinary frequency, urinary tract infection<sup>[Ref]</sup></p><p>A causal relationship between this drug and impotence has not been established.<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Postmarketing reports</b>: Gastroduodenal carcinoids<sup>[Ref]</sup></p><p>Gastroduodenal carcinoids have been reported in patients with Zollinger-Ellison syndrome on long-term therapy.  This condition may be a manifestation of the underlying condition, which is known to be associated with tumors.<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Zegerid (omeprazole)." Santarus Inc, San Diego, CA. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. "Product Information. Prilosec (omeprazole)." Merck &amp; Co, Inc, West Point, PA. </p><p id="ref_5">5. "Product Information. Omeprazole (omeprazole)." Mylan Pharmaceuticals Inc, Morgantown, WV. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>When is the best time to take omeprazole, before or after a meal?</li>
<li>Nexium vs Prilosec: What's the difference between them?</li>
</ul><h2>More about Prilosec (omeprazole)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>43 Reviews</li>
<li>Drug class: proton pump inhibitors</li>
<li>FDA Alerts (6)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Prilosec &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Prilosec OTC</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Barrett's Esophagus</li>
<li>GERD</li>
<li>Duodenal Ulcer</li>
<li>Erosive Esophagitis</li>
<li data-more-config-id="list-data-resources-conditions">... +6 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>